Form 4: Omeros Director Executes Stock Option Exercise and Sale
Insider Transaction Report
Director Thomas J. Cable exercised 7,500 stock options and sold the resulting shares under a pre-established Rule 10b5-1 plan.
Summary
- Director Thomas J. Cable exercised 7,500 stock options at a strike price of $10.84 per share.
- Following the exercise, the director sold 7,500 shares of common stock at a weighted average price of $11.6052 per share.
- The transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on June 14, 2024.
- The director's total beneficial ownership of Omeros common stock stands at 35,067 shares following these transactions.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transaction was pre-planned and represents routine portfolio management by a director.
Positives
- The transaction was executed under a pre-planned Rule 10b5-1 trading plan, indicating a systematic approach rather than reactive selling.
- The exercise of options demonstrates the director's participation in the company's equity incentive programs.
Negatives
- The director reduced their direct beneficial ownership of common stock from 42,567 to 35,067 shares.
Risks
- The options exercised were nearing their expiration date of June 9, 2026, necessitating action to capture value.
Future Outlook
No forward-looking guidance provided; the filing is a routine disclosure of insider transaction activity.
Industry Context
StockSavvy.ai notes that insider sales executed via Rule 10b5-1 plans are standard corporate governance practices used to provide liquidity for executives and directors while mitigating concerns regarding non-public information usage.
Comparison to Industry Standards
- The use of Rule 10b5-1 plans is the industry standard for corporate insiders to manage equity holdings in publicly traded biotechnology companies.
Stakeholder Impact
- Minimal impact on shareholders as the sale was conducted under a pre-established, automated trading plan.
Next Steps
- No further actions required by the reporting person regarding this specific transaction.
Key Dates
| Date | Description |
|---|---|
| 06/14/2024 | Date the Rule 10b5-1 trading plan was adopted. |
| 05/22/2026 | Date of the option exercise and subsequent share sale. |
| 06/09/2026 | Expiration date of the stock options exercised. |
Keywords
Omeros, OMER, Insider Trading, Form 4, Stock Options, Director Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.